Join the Oncology
Community
Follow Us:  
Practice Trends
FDA's New Drug Approvals Outpace Canada, Europe

The Food and Drug Administration reviewed new drug applications significantly faster, and approved more new drugs first,... »

Financial Forecast Bleak for Noncompliance With EHR

SAN DIEGO – A majority of clinicians still lack a qualified electronic health records system and are therefore ineligible... »

Medicare Overhauls Hospital Rules to Cut Red Tape

Hospitals will now have option of including advanced practice nurses, physician assistants, and pharmacists as part of the... »

More Practice Trends »

Cancer Prevention and Epidemiology
Scleroderma Malignancy Risk Linked to Antinuclear Antibodies

GLASGOW, SCOTLAND – The presence of specific autoantibodies may help to predict which patients with systemic sclerosis are... »

Fatty Acids in Fish May Lower Liver Cancer Risk

The consumption of fish rich in n-3 polyunsaturated fatty acids was inversely related to the risk of developing... »

CDC: Indoor Tanning, Sunburns Still Common in Young Adults

Despite the documented increased use of sunscreen and protective clothing in recent years, up to 66% of young adults are... »

More Cancer Prevention & Epidemiology News »

Multimedia
Videos

Sharing bad news with patients or their families can be challenging, but doing it well is a skill that physicians can learn and master, Dr. James Avery says.

Slideshow
The emerging role for PARP inhibitors in BRCA-mutated cancers is reviewed by Community Oncology Editor-in-Chief Dr. Lee Schwartzberg.
Podcasts
The Policy & Practice Podcast covers health care regulation and reform for physicians.
Patient & Survivor Care
Docs Need Primer on Long-Term Effects of Chemotherapy

Many primary care physicians – and even some oncologists – are unaware of common long-term side effects of four widely used... »

Olanzapine Overcomes Chemotherapy-Induced Vomiting and Nausea

The antipsychotic olanzapine trounced standard therapy for breakthrough chemotherapy-induced nausea and vomiting in a... »

Psychiatric Comorbidity Should Not Forestall Cancer Treatment

MIAMI – Serious psychiatric comorbidities should not deprive cancer patients of life-salvaging or life-enriching therapies,... »

More Patient & Survivor Care »

In the Pipeline
Neoadjuvant Abiraterone Helps Clear Aggressive, Early Stage Prostate Tumors

Neoadjuvant abiraterone helped clear tumors in one-third of men with localized, high-risk prostate cancer in an ongoing... »

Panel Recommends Tofacitinib Approval for Refractory RA

SILVER SPRING, MD. – There soon may be a new oral disease-modifying antirheumatic drug in town, the first in more than 10... »

FDA Approves Pazopanib for Advanced Soft-Tissue Sarcomas

Pazopanib, an angiogenesis inhibitor marketed as Votrient, has been approved for the treatment of patients with advanced... »

In the Pipeline »

Views

Clinical News
Scleroderma Malignancy Risk Linked to Antinuclear Antibodies

GLASGOW, SCOTLAND – The presence of specific autoantibodies may help to predict which patients with systemic sclerosis are... »

NICE Reverses Course on Abiraterone

After initially turning it down – and being pressured to reevaluate by the U.K. Department of Health – the clinical... »

Ex Vivo Perfusion Expands Pool of Lung Transplants

SAN FRANCISCO – Additional research continues to show good outcomes with a new process that allows successful transplant of... »

Breast Brachytherapy Judged Superior in Tumor Bed Control

Accelerated partial breast radiation with MammoSite balloon brachytherapy appears to control the tumor bed more effectively... »

Fatty Acids in Fish May Lower Liver Cancer Risk

The consumption of fish rich in n-3 polyunsaturated fatty acids was inversely related to the risk of developing... »

More Clinical News »

Current Issue


The Oncology Report Comprehensive reports and expert commentary on the latest advances in cancer treatment from the world's major oncology meetings.

Past issues, click here »


calendar
Jun 1 - 5
Chicago, IL		 American Society of Clinical Oncology (ASCO): Annual Meeting
Jun 14 - 17
Amsterdam, 		European Hematology Association (EHA): Annual Congress
Jun 18 - 21
Lake Tahoe, NV		 American Association for Cancer Research (AACR): Pancreatic Cancer: Progress and Challenges
Jun 20 - 22
Milan, 		European Institute of Oncology (IEO): 14th Milan Breast Cancer Conference
Jun 25 - 26
London, 		Teenage Cancer Trust (TCT): International Conference
Jun 27 - 30
Barcelona, 		European Society for Medical Oncology (ESMO) Conference: World Congress on Gastrointestinal Cancer
Jun 27 - 30
Boston, MA		 American Association for Cancer Research (AACR): Chemical Systems Biology
Jun 28 - 30
New York, NY		 Multinational Association of Supportive Care in Cancer (MASCC)/ International Society of Oral Oncology (ISOO): International Symposium
Jun 28 - 29
Paris, 		WIN 2012 Symposium
Jul 7 - 10
Barcelona, 		22nd Biennial Congress of the European Association for Cancer Research
More Calendar »